Item 1.01 | Entry into a Material Definitive Agreement. |
On March 26, 2021, Khosla Ventures Acquisition Co. III (the “Company”) consummated its initial public offering (the “IPO”) of 50,000,000 shares of Class A common stock, par value $0.0001 per share (the “Public Shares”) of the Company. The Public Shares were sold at a price of $10.00 per Public Share, generating gross proceeds to the Company of $500,000,000 (before underwriting discounts and commissions and offering expenses). Pursuant to the Underwriting Agreement (defined below), the Company granted the underwriters in the IPO (the “Underwriters”) a 45-day option to purchase up to 7,500,000 additional Public Shares solely to cover over-allotments, if any (the “Over-Allotment Option”); and on March 26, 2021, the Underwriters notified the Company that they were partially exercising the Over-Allotment Option for 6,330,222 additional Public Shares, is expected to be consummated on March 30, 2021, subject to customary closing conditions.
In connection with the IPO, the Company entered into the following agreements, forms of which were previously filed as exhibits to the Company’s registration statement on Form S-1 (File No. 333-253101) (the “Registration Statement”):
| • | | An Underwriting Agreement, dated March 23, 2021, among the Company and Goldman Sachs & Co. LLC and Citigroup Global Markets Inc., as representatives of the several underwriters, attached hereto as Exhibit 1.1. |
| • | | An Investment Management Trust Agreement, dated March 23, 2021, between the Company and Continental Stock Transfer & Trust Company, as trustee, attached hereto as Exhibit 10.1. |
| • | | A Private Placement Shares Agreement, dated March 23, 2021, between the Company and Khosla Ventures SPAC Sponsor III LLC (the “Sponsor”), attached hereto as Exhibit 10.2. |
| • | | A Registration Rights Agreement, dated March 23, 2021, among the Company and certain security holders named therein, attached hereto as Exhibit 10.3. |
| • | | A Forward Purchase Agreement, dated March 23, 2021, among the Company and the Sponsor, attached hereto as Exhibit 10.4. |
| • | | A Letter Agreement, dated March 23, 2021, between the Company, its officers, directors and another securityholder, and the Sponsor, attached hereto as Exhibit 10.5. |
| • | | Indemnity Agreements, each dated March 23, 2021, between the Company and each of its officers and directors, substantially in the form attached hereto as Exhibit 10.6. |
Item 3.02. | Unregistered Sales of Equity Securities. |
Simultaneously with the closing of the IPO, the Company completed the private sale of 1,300,000 shares of Class A common stock, par value $0.0001 per share (the “Private Placement Shares”) at a purchase price of $10.00 per Private Placement Share (the “Private Placement”), to the Sponsor, generating gross proceeds to the Company of $13,000,000. The Private Placement Shares are identical to the Public Shares, except that the Sponsor has agreed not to transfer, assign or sell any of the Private Placement Shares (except to certain permitted transferees) until 30 days after the completion of the Company’s initial business combination. The issuance of the Private Placement Shares was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended.
2